Skip to main content

Paul Mathais

Analyst

Stifel

Equibles does not estimate personal net worth.

About Paul Mathais

Paul Mathais is recorded as Analyst at Stifel. Paul Mathais has spoken on 1 earnings call across 1 company, most recently for Rhythm Pharmaceuticals, Inc. on May 5, 2026. The companies whose calls Paul Mathais spoke on are classified in the Healthcare sector.

Paul Mathais on recent calls

“Taking a step back, it feels like with a number of rare disease launches lately, the street just debates whether early success is a bolus or linear and sustainable.”
Analyst — Stifel, Rhythm Pharmaceuticals, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

  • Stifel

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity